| 641/1507 | US=23 / Câncer Lin SR, Wang JY, Huang MY, Chen CC. Breast cancer patients: detection of circulating cancer cell-related mRNA markers with membrane array method. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 141-55. ISBN 978-1-4020-8368-6. CANCER DE MAMA; DETECCAO DE MARCADORES CIRCULANTES; METODO DE MATRIZ DE MRNA; METODO DE MATRIZ DE MEMBRANA; REACAO DA TRANSCRIPTASE REVERSA |
| 642/1507 | US=28 / Biol/Mol Ribatti D, Ponzoni M. Angiogenesis in malignant and non-malignant pediatric tumors. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 475-86. ISBN 978-1-58829-870-6. |
| 643/1507 | US=28 / Biol/Mol Longo R, Torino F, Gasparini G. Prognostic and predictive significance of surrogate biomarkers of angiogenesis. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 487-508. ISBN 978-1-58829-870-6. |
| 644/1507 | US=28 / Biol/Mol Eder JP, Zuckerman DS. Endpoints for the determination of efficacy of antiangiogenic agents in clinical trials. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 509-24. ISBN 978-1-58829-870-6. |
| 645/1507 | US=28 / Biol/Mol Clamp AR, Jayson GC. The role of imaging in the clinical development of antiangiogenic agents. In: Teicher BA, Ellis LM. Antiangiogenic agents in cancer therapy. 2 ed. Houston: Humana Press, 2008. p. 525-36. ISBN 978-1-58829-870-6. ANGIOGENESE; ENSAIOS CLINICOS; IMAGEM; ANTIANGIOGENICS; DCE-RM; PET; CT FUNCIONAL; ULTRA-SOM |
| 646/1507 | US=23 / Câncer Yie SM. Prediction of metastasis and recurrence of breast carcinoma: detection of survivin-expressing circulating cancer cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 157-74. ISBN 978-1-4020-8368-6. CANCER DE MAMA; METASTASES; CARCINOMA DA MAMA; SURVIVINA; REACAO EM CADEIA DE POLIMERASE; METODOLOGIA ELISA |
| 647/1507 | US=23 / Câncer Xenidis N, Perrakis M, Kakolyris S, Mavroudis D, Georgoulias V. Node-negative breast cancer: predictive and prognostic value of peripheral blood cytokeratin-19 mRNA-positive cells. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 175-88. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CITOQUERATINA-19-MRNA POSITIVOS; CELULAS TUMORAIS CIRCULANTES |
| 648/1507 | US=23 / Câncer Bianco C, Strizzi L, De Luca A, Normanno N, Salomon DS. Breast and colon carcinomas: detection with plasma CRIPTO-1. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 189-202. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMAS DE MAMA; CARCINOMA DE COLON; PLASMA CRIPTO-1; TUMORIGENESE; ELISA |
| 649/1507 | US=23 / Câncer Baltzell K, Mills D, Ljung BM, Love S, Wrensch M. Breast cancer risk in women with abnormal cytology in nipple aspirate fluid. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 203-16. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CITOLOGIA ANORMAL; FLUIDO ASPIRADO; AVALIACAO DE RISCO; DUCTO MAMARIO. ANATOMIA; FLUIDO DO ASPIRADO DE MAMILO; NAF |
| 650/1507 | US=23 / Câncer Mumenthaler SM, Yoon N, Li A, Mah V, Chang G, Nooraie F, Elshimali Y, Hanna S, Kim S, Horvath S, Apple S, Chia D, Seligson DB, Goodglick L. Tissue microarrays: construction and utilization for biomarker studies. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 217-34. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TISSUE MICROARRAYS (TMA); BIOMARCADORES; PROTOCOLOS DE MARCADORES; EXPRESSAO DE BIOMARCADORES; ANALISES DE DADOS; FERRAMENTAS ESTATISTICAS |
| 651/1507 | US=23 / Câncer Kelly CMA, Ryan DN, Penny SA, Gallagher WM. Systematic validation of breast cancer biomarkers using tissue microarrays: from construction to image analysis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 235-50. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TISSUE MICROARRAYS (TMA); VALIDACAO SISTEMATICA DE BIOMARCADORES; CONSTRUCAO DA IMAGEM; ANALISE DE IMAGEM; PELLET CELULAR; IMUNOHISTOQUIMICA |
| 652/1507 | US=23 / Câncer Tan PH, Tse GMK, Yip GWC, Bay BH. Phyllodes tumours of the breast: the role of immunohistochemistry in diagnosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 251-62. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS |
| 653/1507 | US=23 / Câncer Esposito NN, Dabbs DJ. Phyllodes tumours of the breast: prognostic assessment using immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 263-73. ISBN 978-1-4020-8368-6. CANCER DE MAMA; TUMOR PHYLLODES; IMUNOHISTOQUIMICA; AVALIACAO PROGNOSTICA; MARCADORES DE PROLIFERACAO CELULAR; GENES SUPRESSORES DE TUMOR; P53; RECEPTORES DE ESTEROIDES; PROTEINAS; FATORES DE CRESCIMENTO EPIDERMICO; HER-2/NEU; ANALISE CROMOSSOMICA; ANALISE MOLECULAR; ANALISE HISTOPATOLOGICA |
| 654/1507 | US=23 / Câncer Tot T. Metaplastic breast carcinoma: detection using histology and immunohistochemistry. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 275-90. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CARCINOMA DE MAMA METAPLASICO; HISTOLOGIA; IMUNOHISTOQUIMICA; CARACTERISTICAS CLINICO-PATOLOGICAS; PROGNOSTICO |
| 655/1507 | US=23 / Câncer van Diest PJ, Moelans CB, Purnomosari D, Pals G, de Weger RA. Invasive breast cancer: overexpression of HER-2 determined by immunohistochemistry and multiplex ligation-dependent probe amplification. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 291-304. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA INVASIVO; SUPEREXPRESSAO DE HER-2; IMUNOHISTOQUIMICA; LIGADURA MULTIPLEX DEPENDENTE |
| 656/1507 | US=23 / Câncer Kaufmann M, Loibl S, von Minckwitz G. Operable breast cancer: neoadjuvant treatment (methodology). In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 305-18. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA OPERAVEL; TRATAMENTO NEOADJUVANTE; CANCER DE MAMA. DIAGNOSTICO; CANCER DE MAMA. TRATAMENTO |
| 657/1507 | US=23 / Câncer McCubrey JA, Franklin RA, Navolanic PM, Martelli AM, Steelman LS. Chemotherapy for breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 319-25. ISBN 978-1-4020-8368-6. CANCER DE MAMA; QUIMIOTERAPIA; METOTREXATO; 5-FLUOROURACIL; CICLOFOSFAMIDA; ANTRACICLINA; TAXANOS; TRASTUZUMABE; TAMOXIFENO; INIBIDORES DE AROMATASE |
| 658/1507 | US=23 / Câncer Frasci G, D'Aiuto G, Iodice G, D'Aiuto M, Comella G. Locally advanced breast cancer: role of chemotherapy in improving prognosis. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 327-49. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA LOCALMENTE AVANCADO; QUIMIOTERAPIA; QUIMIOTERAPIA PRE-OPERATORIA; QUIMIOTERAPIA POS-OPERATORIA; TRATAMENTO NEOADJUVANTE; TERAPIA-ALVO |
| 659/1507 | US=23 / Câncer Kummel S, Rezai M, Kimmig R, Schmid P. Relevance of dose-intensity for adjuvant treatment of breast cancer. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 351-60. ISBN 978-1-4020-8368-6. |
| 660/1507 | US=23 / Câncer Pallis AG, Georgoulias V, Mavroudis V. Advanced breast cancer: treatment with docetaxel/epirubicin. In: Hayat MA. Methods of cancer diagnosis, therapy and prognosis: breast carcinoma. v.1. New York: Springer, 2008. p. 361-71. ISBN 978-1-4020-8368-6. CANCER DE MAMA; CANCER DE MAMA AVANCADO; CANCER DE MAMA. TRATAMENTO; DOCETAXEL; EPIRRUBICINA; COMBINACAO ANTRACICLINA-TAXANO; COMBINACAO DOCETAXEL EPIRRUBICINA; DADOS FARMACOCINETICOS |